Month: July 2021

Basel, Switzerland, July 29, 2021 Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Basilea’s tumor checkpoint controller, lisavanbulin, for the treatment of malignant glioma (brain cancer). This includes glioblastoma, the most common type of primary brain cancer and one of the most lethal types of cancer.1 Orphan Drug Designation qualifies the sponsor of the drug for various incentives, including longer regulatory market exclusivity. Dr. Marc Engelhardt, Chief Medical Officer, commented: “The Orphan Drug Designation of lisavanbulin by the U.S. FDA is an important milestone for the development of lisavanbulin. Glioblastoma is associated with a poor prognosis and there are only very limited therapeutic options available. Lisavanbulin, as a targeted...

[Ad hoc announcement pursuant to art. 53 SIX Listing Rules] This press release is also available in Français (pdf) and Deutsch (pdf) Follow today’s event live 14:00 CEST Investor call audio webcast Full details on our website Report published today2021 Half-Year Report (pdf) Other language versions available in Publications …………. Vevey, July 29, 2021 Nestlé reports half-year results for 2021, raises full-year organic sales growth guidanceOrganic growth reached 8.1%, with real internal growth (RIG) of 6.8% and pricing of 1.3%. Growth was supported by continued momentum in retail sales, a return to growth in out-of-home channels, increased pricing and market share gains. Total reported sales increased by 1.5% to CHF 41.8 billion (6M-2020: CHF 41.2 billion). Foreign exchange reduced sales by 3.5%, reflecting...

Please find attached HiPay official Press Release related to HiPay Results in H1 2021. About HiPay HiPay is a global payment provider. By harnessing the power of payment data, we participate in our merchants’ growth by bringing them a 360° vision of their activities. HiPay Group is listed on the Euronext Paris Compartment C (ISIN code: FR0012821916 – Mnemo: HIPAY) More information on hipay.com and find us on LinkedIn. Press Contact Vae Solis Communications Jawad Khatib +33 (0)6 12 66 22 49 jawad.khatib@vae-solis.com   This press release does not constitute an offer to sell or the solicitation of an offer to buy HIPAY securities. If you would like more complete information about HiPay Group, please refer to our website hipay.com, Investors section. This press release may contain certain forward-looking statements. Although HiPay...

NEW YORK, July 28, 2021 (GLOBE NEWSWIRE) — Value Line, Inc., (NASDAQ: VALU) reported results for the fiscal year ended April 30, 2021. During the twelve months ended April 30, 2021, the Company’s net income of $23,280,000, or $2.43 per share, was 55.8% above net income of $14,943,000, or $1.55 per share, for the twelve months ended April 30, 2020. Earnings for the fiscal year ended April 30, 2020 were revised, as were earnings for the fiscal year ended April 30, 2019, to reflect the required adoption of FASB ASU 2016-01 effective for the fiscal year beginning May 1, 2018 and ending April 30, 2019. This change transferred unrealized gains and losses on equity securities to earnings, from comprehensive income. Shareholders’ equity remains unchanged for each of the fiscal years ended April 30, 2019 and 2020. The largest factors in...

WILMINGTON, DE, July 28, 2021 (GLOBE NEWSWIRE) — Colfax Corporation (“Colfax” or the “Company”) (NYSE: CFX), a leading diversified technology company, announced today the pricing of an underwritten secondary offering by certain of its stockholders (the “Selling Stockholders”) of 6,544,522 shares of the Company’s common stock at a public offering price of $43.90 per share. The shares are expected to be delivered on or about August 2, 2021, subject to customary closing conditions. The Selling Stockholders will receive all of the net proceeds from the offering. The Company is not selling any shares of common stock in the offering and will not receive any proceeds from the offering. Morgan Stanley is acting as sole book-running manager for the offering. The offering is being made pursuant to a shelf registration statement on Form...

OAKLAND, Calif., July 28, 2021 (GLOBE NEWSWIRE) — ThredUp Inc. (Nasdaq: TDUP) (“thredUP”), one of the largest online resale platforms for women’s and kids’ apparel, shoes and accessories, announced today the pricing of the public offering of 6,424,369 shares of its Class A common stock, consisting of 2,000,000 shares to be issued and sold by thredUP and 4,424,369 shares to be sold by existing stockholders of thredUP, at a public offering price of $24.25 per share. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to 963,655 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on August 2, 2021, subject to customary closing conditions. thredUP intends to use the net proceeds from the...

Across four phase III studies, approximately half of patients receiving faricimab could extend treatment time to every four months – the first time this level of durability has been achieved in phase III nAMD and DME studies If approved, faricimab would be the first and only medicine designed to target two distinct pathways that drive retinal diseases that can cause vision loss The European Medicines Agency has also validated the faricimab Marketing Authorisation Application submission in nAMD and DMEBasel, 29 July 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA), under Priority Review, for faricimab for the treatment of neovascular or “wet” age-related macular degeneration (nAMD) and diabetic macular edema...

VANCOUVER, British Columbia, July 28, 2021 (GLOBE NEWSWIRE) — Dominion Lending Centres Inc. (TSXV:DLCG) (“DLCG” or the “Corporation”) has been served with a Notice of Civil Claim (the “Claim”) filed in the Supreme Court of British Columbia by Canadian Mortgage Experts Inc. and Michael Lloyd (collectively, “CME”). Pursuant to the Claim, CME alleges various misconduct by DLCG as a franchisor, all of which DLCG denies. The Corporation and CME have been parties to a franchise agreement for over 10 years and did enter into an amended and restated franchise agreement dated January 1, 2020 (the “Franchise Agreement”). In addition to CME being a DLC franchisee, we understand that its principal is a stakeholder in a technology company that competes with the Corporation’s subsidiary Newton Connectivity Systems Inc. (“Newton”). Pursuant to...

TORONTO, July 28, 2021 (GLOBE NEWSWIRE) — Kirkland Lake Gold Ltd. (“Kirkland Lake Gold” or the “Company”) (TSX:KL) (NYSE:KL) (ASX:KLA) today announced the Company’s financial and operating results for the second quarter (“Q2 2021”) and first six months (“YTD 2021”) of 2021. The results included record quarterly net earnings and earnings per share driven by strong operating results and revenue growth, largely reflecting continued outperformance at Fosterville. All three of the Company’s cornerstone assets increased production compared to both the second quarter of 2020 (“Q2 2020”) and the previous quarter (“Q1 2021”).  The Company also reported solid earnings growth in YTD 2021 compared to the first six months of 2020 (“YTD 2020”), resulting largely from increased revenue. The Company’s full financial statements and management discussion...

MENLO PARK, Calif., July 28, 2021 (GLOBE NEWSWIRE) — Robinhood Markets Inc. today announced the pricing of its initial public offering of 55,000,000 shares of its Class A common stock at a price to the public of $38.00 per share. In the offering, 52,375,000 shares are being offered by Robinhood and 2,625,000 shares are being offered by existing stockholders. The underwriters will have a 30-day option to buy an additional 5,500,000 shares from Robinhood at the initial public offering price, less underwriting discounts and commissions. The net proceeds to Robinhood from the sale of Class A common stock in this offering will be approximately $1.89 billion. Robinhood will not receive any proceeds from the sale of shares by the selling stockholders. Robinhood intends to use the net proceeds for working capital, capital expenditures,...